- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$289 MnMarket Estimate, 2026
$305 MnMarket Forecast, 2034
$468 MnCAGR, 2026–2034
5.5%Global Tuberculin Market Size, Growth, Trends & Forecast (2026–2034)
The size of the global tuberculin market was valued at USD 289 million in 2025, is anticipated to reach USD 304.90 million in 2026, and is projected to scale up to USD 468 million by 2034, registering a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2026 to 2034. Driven by the rising incidence of tuberculosis worldwide, increasing government screening initiatives, and enhanced public-private investments, the global market continues to witness steady growth across diagnostic and veterinary sectors.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 289 Million
- 2026 Current Valuation: USD 304.90 Million
- 2034 Forecast Valuation: USD 468 Million
- Compound Annual Growth Rate (CAGR): 5.5% (2026–2034)
- Dominant Product Type & Application: PPD-S Product Type / Human Use Application (leading market share)
- Fastest-Growing Product Type & Application: PPD RT23 Product Type / Animal Use Application (expanding via rising veterinary research)
- Dominant Region & Fastest-Growing Region: North America (leading with advanced healthcare infrastructure) / Asia-Pacific (fastest growth due to high TB prevalence in India and Southeast Asia)
Core Market Drivers
- Rising TB Prevalence: Global increase in tuberculosis cases and lifestyle-related health vulnerabilities boosting diagnostic demand.
- Government & Institutional Support: Expanded public health awareness campaigns, increased private-public funding, and novel drug development (e.g., TB Alliance FDA approvals).
Primary Market Restraints & Challenges
- Product Recalls & Side Effects: Manufacturing or packaging flaws leading to drug recalls, coupled with injection-site reactions (swelling, irritation) and false-positive risks from prior BCG vaccinations.
- Economic & Access Barriers: High costs associated with advanced second-line treatments and disparities in healthcare technology access across developing regions.
Global Tuberculin Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (2025 Base) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Product Type | PPD-S (predicted to lead with the highest market share backed by R&D advancements) | PPD RT23 (steady growth supported by rising population and new infection cases) |
| By Application | Human Use (leading market share driven by global population growth and screening campaigns) | Animal Use (growing via expanding veterinary research experiments and funding initiatives) |
| By Region | North America (leading share through cutting-edge technology adoption and robust clinical trials) | Asia-Pacific (fastest growth rate propelled by high TB incidence rates in India and Southeast Asia) |
Major Industry Players Profiled
Key enterprises shaping the competitive global tuberculin market include SSI, Sanroad Biological, Pasteur, Thermo Fisher, Japan BCG, Par Sterile, CNBG, CZ Veterinaria, and Zoetis.
Global Tuberculin Market Size
The size of the global tuberculin market was worth USD 289 million in 2025. The global market is anticipated to grow at a CAGR of 5.5% from 2026 to 2034 and be worth USD 468 million by 2034 from USD 304.90 million in 2026.
MARKET DRIVERS
The Growing Incidence Of Tuberculosis Around The World Is Majorly Promoting The Global Tuberculin Market Growth.
Increased government efforts to ensure the availability of these types of drugs and raise public awareness have aided the market's development. People have been able to use these medications and boost their growth rate as economies have grown and disposable income has increased. The advancement of technology in this area has been used to boost these drugs' effectiveness and widen their market.The demand for tuberculosis drugs is rising as a result of an increasing number of drug advances. The TB Alliance, a nonprofit organization based in the United States, has created a new drug for treating tuberculosis that is extremely drug-resistant. For instance, TB Alliance received FDA approval in August 2019 for Pretomnid, a bedaquiline and linezolid combination regimen developed and indicated for the treatment of patients with XDR-TB or intolerant non-responsive MDR-TB.The global tuberculin market is projected to hit new heights in the coming years of the forecast period due to increased funds and investments from the private and public sectors. Furthermore, numerous government-sponsored health-awareness programs worldwide are assisting in the development of the global tuberculin industry. Another important factor expected to drive the tuberculin market's expansion is the increasing research and development activities.
MARKET RESTRAINTS
The increasing number of drug recalls is a major hurdle to the market's expansion.
Manufacturers of tuberculosis drugs face a rise in product recalls due to packaging or manufacturing flaws. In India, for instance, Sandoz recalled a batch of tuberculosis (TB) drugs due to improper packaging. Furthermore, the Philippines Food and Drug Administration recalled Novartis' drug Onecure in 2016 due to an inadequate amount of rifampicin in the drug. Another factor restricting the market's growth is the high cost of medicines. Second-line treatment drugs are more expensive than first-line treatment drugs, and they have more adverse effects and high levels of toxicity.Tuberculin's side effects are a significant challenge to the market's expansion. Irritation, swelling, and discomfort at the injection site are now being reported in a significant number of cases, which is causing the industry to decline. The test may be falsely positive in those who have previously received BCG vaccination or have been contaminated with other forms of mycobacterium, posing a risk to the market's profitable development. Tuberculin use during pregnancy is still being studied. These are the challenges faced by the Tuberculin market.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Market Leaders Profiled | SSI, Sanroad biological, Pasteur, Thermo Fisher, Japan BCG, Par sterile, CNBG, CZ Veterinaria, and Zoetis., and Others. |
SEGMENTAL ANALYSIS
By Product Type Insights
The PPD-S product type is predicted to lead with the highest share in the global tuberculin market in 2025 and is expected to grow positively during the forecast period. There is an increase in research and development institutes trying to introduce safe and efficient drugs. The progress of these institutes has helped the market to grow at a reasonable rate. The increasing prevalence of unhealthy lifestyles has led to more tuberculosis cases, thus contributing to the tuberculin market growth rate.PPD RT23 had the second-largest market share in 2025 and is expected to grow reasonably during the forecast period. The rising number of new tuberculosis cases due to the increased population and unhealthy lifestyles have positively impacted the market growth.
By Application Insights
Based on the application, the Human use segment was the leading market share in 2025 and is expected to grow with the highest CAGR during the forecast period. The rise in the human population around the globe is the primary factor in increasing the growth rate. The prevalence of unhealthy lifestyles on people due to changing food habits and exercise routines has also led to more tuberculosis cases and improved the tuberculin market. The rise in investments by governments worldwide to reduce the costs associated with and increase the efficiency of this drug has positively influenced market growth. Increasing awareness among people through social campaigns and digital advertisements has helped the market to grow.Animal use had the second-largest market share in 2025 and is expected to grow at a reasonable growth rate during the forecast period. The increase in the number of experiments and research activities has increased market growth. Most of these experiments and research are being done on animals. The market is expected to grow as more funding and government initiatives are being introduced to boost this field's research process.
REGIONAL ANALYSIS
North America Tuberculin Market Analysis
North America is accounted for in leading the highest shares of the market by adopting the latest technology and the launch of innovative products in favor of the end-user. North America had the largest market share in 2025 and is expected to grow at a reasonable growth rate during the forecast period. The increasing prevalence of tuberculosis is the primary factor supporting the growth rate. The other reasons propelling the market are many ongoing clinical trials and the availability of improved treatment options and healthcare infrastructure. Adopting the latest technology and the launch of innovative products favorable for the end-user has also positively affected the market. The presence of global players is going to ensure the continuation of market growth.
Europe Tuberculin Market Analysis
Europe had the second-largest market share in 2025 and is expected to grow at a healthy future rate. The increasing diabetes cases due to the prevalence of unhealthy lifestyles and the growing quality of healthcare facilities will support the positive growth of this region.Asia Pacific market is expected to grow at the fastest rate among other regions. India and Southeast Asia are significant markets due to high cases of tuberculosis. These increasing cases at a very high rate are the primary reason for the highest growth rate. Increasing incidences of tuberculosis are primary factors boosting the growth of the market in the Asia Pacific. Increasing capital income in most countries is escalating the growth of the market in Europe. The Middle East and Africa are anticipated to have a prominent growth rate in the near future.
KEY MARKET PLAYERS
Some of the major companies in the global tuberculin market profiled in this report are
- SSI
- Sanroad Biological
- Pasteur
- Thermo Fisher
- Japan BCG
- Par Sterile
- CNBG
- CZ Veterinaria
- Zoetis
MARKET SEGMENTATION
This research report on the global tuberculin market has been segmented and sub-segmented into the following categories.
By Product Type
- PPD-S
- PPD RT23
By Application
- Human Use
- Animal Use
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa